Cáncer vesical: Aspectos generales y epidemiológicos, diagnóstico histopatológico, clasificación clínico-patológica, diagnóstico de extensión y grupos de riesgo

Archivos Espanoles de Urologia

Volumn 52, Issue 6, 1999, Pages 553-563

  Vera Donoso, César David ^a   Jiménez Cruz, Juan Fernando ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bladder; Cancer; Diagnosis; Epidemiology; Risk groups; Staging

Indexed keywords

AGED; BLADDER TUMOR; CLASSIFICATION; FEMALE; HUMAN; MALE; PATHOLOGY; PREVALENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE;

AGED; FEMALE; HUMANS; MALE; PREVALENCE; RISK FACTORS; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0042941250     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. OTERO, G.; FERNÁNDEZ, A.; GIL FABRA, J.: " Epidemiología descriptiva y analítica en oncología urológica. " Ene Ediciones. Madrid, 1998.
2. MAYFIEED, M.P.; WHELAN, P.: " Bladder tumours detected on screening: results at 7 years. " Br. J. Urol., 82: 825, 1998.
3. MESSING, E.M.; YOUNG, T.B.; HUNT, V.B. y cols.: " Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. " Urology, 45: 387, 1995.
4. SAKR, W.A.; GRIGNON, D.J.; CRISSMAN, J.D.: " Histopathology of transitional cell carcinoma of the urinary bladder. " Current Opinion in Urology, 7: 287, 1997.
5. ALGABA, F.; MORENO, A.; TRIAS, I.: " Tumores de las vías urinarias. " Algaba F. (ed.). Uropatología Tumoral. Barcelona, Ed. Pulso 1996; 103-211.
6. MURPHY, W.M.; BECKWITH, J.B.; FARROW, J.M.: " Tumors of the kidney, bladder, and related urinary structures. " Atlas of Tumor Pathology, 3rd series. Rosai J. (ed.); Washington DC, Armed Forces Institute of Pathology, 1994; p. 248.
7. JORDAN, A.M.; WEINGARTEN, J.; MURPHY, W.M.: " Transitional cell neoplasms of the urinary bladder; can biological potential be predicted from histological grade? " Cancer, 60: 2766, 1987.
8. PROUT, G.R.; BARTON, B.A.; GRIFFIN, P.P. y cols.: " Treated history of non-invasive grade 1 transitional cell carcinoma. " J. Urol., 148: 1413, 1992.
9. CARBIN, B.E.; EKMAN, P.; GUSTAFSON, H. y cols.: " Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. I: Histological description. " J. Urol., 145: 968, 1991.
10. CARBIN, B.E.; EKMAN, P.; GUSTAFSON, H. y cols.: " Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. II: Prognostic importance. " J. Urol., 145: 972, 1991.
11. TETU, B.; ALLARD, P.; FRADET, Y. y cols.: " Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancer. " Hum. Pathol., 27: 922, 1996.
12. HARNDEN, P.; ALLAM, A.; JOYCE, A.D. y cols.: " Cytokeratin 20 expression by non-invasive transitional cell carcinoma: potential for distinguishing recurrent from non-recurrent disease. " Histopathology, 27: 169, 1995.
13. GAZZANIGA, P.; GRADILONE, A.; VERCILLO, R. y cols.: " bcl 2/ bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer. " Int. J. Cancer, 69: 100, 1996.
14. TETU, B.; FRADET, Y.; ALLARD, P. y cols.: " Prevalence and clinical significance of Her-2/neu, p53 and Rb expression in primary superficial bladder cancer. " J. Urol., 155: 1784, 1996.
15. WOLF, H.; ROSENICILDE OLSEN, P.; FISCHER, A. y cols.: " Urothelial atypia concomitant with primary bladder tumor. " Scand. J. Urol. Nephr., 21: 33, 1987.
16. ZINCKE, H.; UTZ, D.C.; FARROW, G.M.: " Review of Mayo Clinic experience with carcinoma in situ. " Urology, 26 (suppl.): 39, 1985.
17. DONA, S.T.; FLAMM, J.: " The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma. " Eur. Urol., 16: 81, 1989.
18. MUFTI, G.R.; SINGH, M: " Value of random mucosal biopsies in the management of superficial bladder cancer. " Eur. Urol., 22: 288, 1992.
19. FARROW, G.M.; UTZ, D.C.: " Observations on microinvasive transitional cell carcinoma of the urinary bladder. " Clin. Oncol., 1: 609, 1982.
20. YOUNG, R.H.; WICK, M.R.; MILLS, S.E.: " Sarcomatoid carcinoma of the urinary bladder. A clinicopathological analysis of 12 cases and review of the literature. " Am. J. Clin. Pathol., 90: 653, 1988.
21. FARROW, G.M.; UTZ, D.C.; RIFE, C.C. y cols.: " Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. " Cancer Res., 37: 2794, 1977.
22. JIMÉNEZ CRUZ. J.F.; RIOJA SANZ, L.A.: " Tratado de Urología. " Barcelona 1993. Proas Ed. pag. 1169.
23. HATCH, T.R.; BARRY, J.M.: " The value of excretory radiography in staging bladder cancer. " J. Urol., 135: 49, 1986.
24. CORRAL, D.; SLATON, J.W.; PERROTTE, P. y cols.: " Examination under anesthesia (EUA) in the staging and management of bladder cancer in the contemporary era. " J. Urol., 159: A 819, 1998.
25. WALLACE, D.M.A.; HINDMARSH, J.R.; WEBB, J.N. y cols.: " The role of multiple biopsies in the management of patients with bladder cancer. " Br. J. Urol., 51: 535, 1979.
26. VICENTE, J.; ALGABA, F.: " Semiología Diagnóstica Endovesical. " Ed Pulso, Barcelona 1998, pag 163.
27. JIMÉNEZ CRUZ, J.F.; LLOPIS MINGUEZ, B.; VERA-DONOSO, C.D.: " Carcinoma vesical superficial primario. Factores pronósticos de recidiva. " Arch. Esp. Urol., 43 (Suppl. 2): 139, 1990.
28. BARENTSZ, J.O.; LEMMENS, J.A.M.; RUIJS, S.H.J. y cols.: " Carcinoma of urinary bladder: MR imaging with a double surface coil. " Am. J. Roentgenol., 151: 107, 1988.
29. TACHIBANA, M.; BABA, S.; DEGUCHI, N. y cols.: " Efficacy of gadolinium DTPA enhanced MRI for differentiating between superficial and muscle invasive tumor for the bladder: a comparative study with CT and ultrasonography. " J. Urol., 145: 1169, 1991.
30. SEE, W.A.; FULLER, J.R.: " Staging of advanced bladder cancer. Current concepts and pitfalls. " Urol. Clin. North Am., 19: 663, 1992.
31. ABEL, P.D.; HALL, R.R.; WILLIAMS, G.: " Should pT1 transitional cell cancers of the bladder still be classified as superficial? " Br. J. Urol., 62: 235, 1988.
32. ZIEGER, K.; WOLF, H.; OLSEN, P.R. y cols.: " Long-term survival of patients with bladder tumours: the significance of risk factors. " Br. J. Urol., 82: 667, 1998.
33. SMITS, G.; SCHAAFSMA, E.; KIEMENEY, L. y cols.: " Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. " Urology, 52: 1009, 1998.
34. KOCH, M.O.; SMITH, J.A. Jr.: " Natural history and surgical management of superficial bladder cancer (Stages Ta, T1, Cis). " En: Comprehensive Textbook of Genito-urinary Oncology. Volgezan, N.J.; Scardino, P.T.; Shipley, W.U. y Coffey, D. (Eds.) Williams & Wilkins Ed. Baltimore 1996. Pag 407.
35. PAGANO, S.; FRANZOSO, F.; PACHERA, F. y cols.: " T1G3 bladder tumors: our experience. " Arch. Ital. Urol. Androl., 68: 39, 1996.
36. CHISENA. S.; ANTONLLI, D.; BERNASCONI, S. y cols.: " T1G3 of the bladder: our experience. " Arch. Ital. Urol. Androl., 68: 51, 1996.
37. HOLGMAN, S.; HEDELIN, H.; ANDERSTROM, C. y cols.: " The importance ot the depth of invasion in stage T1 bladder carcinoma: a prospective cohort sdudy. " J. Urol., 157: 800, 1997.
38. WEINSTEIN, R.S.; MILLER, A.W. III y PAULI, B.U.: " Carcinoma in situ: comments on the pathobiology of a paradox. " Urol. Clin. North Am., 7: 523, 1980.
39. FARROW, G.M.; UTZ, D.C.; RIFE, C.C.: " Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. " Cancer Res., 36: 2495, 1976.
40. LAMM, D.L.: " Carcinoma in situ. " Urol. Clin. North Am., 19: 442, 1992.
41. HUDSON, M. y LAMM, D.: " Carcinoma in situ of the bladder. " J. Urol., 153: 564, 1995.